Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus

BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4i) decrease glucose levels by regulating incretin peptides in type 2 diabetes mellitus (T2DM). This study aimed to determine the modulatory effect of DPP-4i on brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Liying, Wang, Zhuo, Ren, Jinmei, Xiong, Xiaowei, Jin, Zening, Liu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842815/
https://www.ncbi.nlm.nih.gov/pubmed/35164839
http://dx.doi.org/10.1186/s13098-022-00797-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842815/
https://www.ncbi.nlm.nih.gov/pubmed/35164839
http://dx.doi.org/10.1186/s13098-022-00797-x

Ejemplares similares